AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)
Completed · Not applicable
Conditions studied: Vascular Access Complication
In brief
The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (PIV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to Conventional IV Catheters.
Key facts
- Study ID
- NCT01937195
- Run by
- C. R. Bard
- People needed
- 95
- Starts
- 2013-04-01
- Expected to finish
- 2014-11-01
- Last updated by the study team
- 2017-04-20
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female, age > or equal to 18 years or < or equal to 89 years old;
- Capable and willing to give informed consent;
- English speaking;
- Acceptable candidate for an elective, non-emergent PIV as determined by ordering physician;
- Admitted to study inpatient unit.
You may not qualify if…
- Male or female, < 18 years old or > 89 years old;
- Requirement for emergent IV placement (patient's condition would be compromised if there is a delay in IV placement);
- Previous venous grafts or surgery at the target vessel access site;
- Currently involved in other investigational clinical trials (unless permission is granted by other study PI);
- Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating.
Where it is running
- Evangelical Community Hospital — Lewisburg, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.